Life Sciences Products & Reviews

A high-performance product for fluorescent probe-based PCR applications, including quantitation and SNP genotyping.

Fluorescent cholera toxin subunit B (CTB) conjugates that are optimized for bright and clean staining of extracellular vesicles for flow cytometry.

Superior RNA extraction from FFPE (paraffin) tissue sections with 3 to 30-fold increase in yield, and 2-fold increase in DV200 (RNA longer than 200 nucleotides) compared to other methods.

Superior DNA extraction from FFPE samples, due to the enhanced removal of formaldehyde-induced damage, providing DNA with higher yield and quality and greater amplifiability.

Label your antibody with one of our superior CF ®  Dyes in 15 minutes without a purification step. Labeling tolerates many common buffer components including BSA and ascites.

This unique reagent quenches lipofuscin autofluorescence in tissue sections for immunofluorescence staining and can also help to reduce autofluorescence from other sources like extracellular matrix.

Buffer system optimized for fluorescence-based western provides superior specificity, sensitivity, and background suppression.

A buffer set that blocks non-specific antibody binding as well as direct interaction of fluorescent dyes on antibodies with cells or tissue sections.

A visible, blue protein gel staining solution. Fast protein staining in a single step without fixation or washing.

Sensitive and easy-to-use RNA prestain loading dye allows RNA to be evaluated on a regular agarose gel.

BioIVT provides isolated exosomes from a variety of human, animal, and plant sources, as well as custom characterization and in vitro assays investigating function and potential therapeutic benefit.

BioIVT offers high quality, normal and disease state, fresh mobilized and cryopreserved leukopaks, custom collected or sourced from extensive inventory, featuring a diverse donor pool including over 600 HLA-typed recallable, consented donors near biotech hubs in the US and UK.

BioIVT’s extensive, highly characterized, normal and disease-state tissue samples are collected and prepared under strict ethical and QC policies and feature detailed clinical data as well as pathologist verification of disease tissue blocks to help ensure the accuracy of your research. Custom collections or extensive inventory are available from a diverse donor pool or any commercially available species.

Access 30+ years of BioIVT’s vast biobank collections’ clinical data, biospecimen imaging and biomarker findings. Delve into AI-ready datasets for oncology, neurology and more that meet regulatory requirements, ethical standards and privacy laws.

BioIVT is the leading provider of quality, highly characterized, ethically procured ADME research products, featuring custom preparation or extensive ready-to-ship inventory, large lot sizes and expert support.

Isolated immune cells play a crucial role across the stages of drug discovery and development from biomarker and target identification through screening and safety assessment to manufacturing. They can be used to create disease models, cell lines, gene editing techniques and more.

BioIVT has the expertise in the processes required for ethical acquisition of biospecimens that cover a wide range of disease states and the protocols needed to produce reliable data. With over 425 IRB-approved clinical sites, BioIVT provides clinical specimens for nearly all disease states.

BioIVT supplies high quality, ready to ship or custom plasma, serum, and whole blood—both normal and disease-state—collected from a diverse pool of consented donors under IRB-approved protocols or a wide variety of species.

As the world's largest private repository of human cerebrospinal fluid, BioIVT’s Center for NeuroExcellence offers 35,000+ healthy and 113,000+ diseased donor samples allowing for comparative studies and precise control matching. The samples are ethically collected following strict quality standards and feature detailed clinical data and matching blood, plasma, or sera.

With decades of drug metabolism, drug-drug interactions (DDI) and related expertise, BioIVT’s experts can provide you with the right studies to understand the properties and potential risks of your compound when it’s most critical for your program.

Target Sufficiency® is the ability of a target system to respond to a therapeutic. It reflects the abundance and forms of the drug target protein, as well as other key system proteins that connect the target to disease phenotypes and enable response. Assessment of the target system requires an analysis platform that can simultaneously capture multiple precise protein measurements.

Plasmax™ is a physiologically relevant cell culture medium which closely mimics the nutritional & metabolic profile of human plasma, containing over 80 optimised components.

Syngeneic urothelial carcinoma model for bladder cancer research and immunotherapy development

Highly metastatic murine alveolar lung carcinoma cell line, derived from the CMT 64 line, that is widely used to investigate metastasis, immune responses, and immunoresistance.

Syngeneic pancreatic ductal adenocarcinoma (PDA) cell line from the KPC mouse model for immune-competent studies in drug discovery, biomarker development, genetic research, and metastasis